tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market
Advertisement

AbbVie (4AB) Technical Analysis

Compare
25 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 1.52, suggesting AbbVie is a Buy.
AbbVie’s (4AB) 20-Day exponential moving average is 197.54, while AbbVie’s (4AB) share price is €196, making it a Sell.
AbbVie’s (4AB) 50-Day exponential moving average is 193.49, while AbbVie’s (4AB) share price is €196, making it a Buy.

AbbVie (4AB) Pivot Points

Nov 30, 2025, 01:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
194.67
195.33
195.67
196.33
196.67
197.33
197.67
Fibonacci
195.33
195.72
195.95
196.33
196.72
196.95
197.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Nov 30, 2025, 01:39 PM
Period
Simple
Exponential
MA5
198.78Sell
197.86Sell
MA10
200.38Sell
198.49Sell
MA20
195.97Buy
197.54Sell
MA50
195.35Buy
193.49Buy
MA100
184.00Buy
186.82Buy
MA200
176.69Buy
180.10Buy
AbbVie’s (4AB) 10-Day exponential moving average is 198.49, while AbbVie’s (4AB) share price is €196, making it a Sell.
AbbVie’s (4AB) 100-Day exponential moving average is 186.82, while AbbVie’s (4AB) share price is €196, making it a Buy.
AbbVie’s (4AB) stock price is €196 and AbbVie’s (4AB) 50-day simple moving average is 195.35, creating a Buy signal.
AbbVie’s (4AB) stock price is €196 and AbbVie’s (4AB) 100-day simple moving average is 184.00, creating a Buy signal.
AbbVie’s (4AB) stock price is €196 and AbbVie’s (4AB) 200-day simple moving average is 176.69, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Nov 30, 2025, 01:39 PM
Name
Value
Implied Action
RSI (14)
48.89
Neutral
STOCH (9,6)
2.59
Buy
STOCHRSI (14)
45.08
Neutral
MACD (12,26)
1.52
Buy
ADX (14)
19.19
Buy
Williams %R
-67.38
Buy
CCI (14)
2.41
Neutral
ATR (14)
3.79
-
Ultimate Oscillator
48.33
Neutral
ROC
5.15
Buy
AbbVie’s (4AB) Relative Strength Index (RSI) is 48.89, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 19.19, creating a Buy signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is 2.41, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is 5.15, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 48.89, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 1.52, which suggests 4AB is a Buy.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 198.78, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 195.97, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 195.35, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 176.69, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -67.38, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 2.41, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis